project id: TCGA-PAAD; case submitter id: TCGA-H8-A6C1; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.82; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.35; rna integrity number: 7.1; age at index: 53; days to birth: -19677; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1959; age at diagnosis: 19677; ajcc pathologic m: MX; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 671.0; icd 10 code: C25.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Head of pancreas; synchronous malignancy: No; tissue or organ of origin: Head of pancreas; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Yes; cigarettes per day: 1.643835616438356; pack years smoked: 30.0; years smoked: 30.0; is ffpe: false; composition: Not Reported; days to collection: 198; days to sample procurement: 0; initial weight: 90.0; portion submitter id: TCGA-H8-A6C1-01A-11; percent lymphocyte infiltration: 10.0; percent monocyte infiltration: 2.0; percent necrosis: 3.0; percent neutrophil infiltration: 2.0; percent normal cells: 3.0; percent stromal cells: 74.0; percent tumor cells: 20.0; percent tumor nuclei: 65.0;